Global Nuclear Radiopharmaceutical Supply, Demand and Key Producers, 2023-2029

Global Nuclear Radiopharmaceutical Supply, Demand and Key Producers, 2023-2029

The global Nuclear Radiopharmaceutical market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Nuclear Radiopharmaceuticals consist primarily of a radioactive isotope that is incorporated into a drug to assess the disease state in the body. The drug is used to deliver the radioactive isotope to an organ, tissue or specific cell in the body.

This report studies the global Nuclear Radiopharmaceutical production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Nuclear Radiopharmaceutical, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Nuclear Radiopharmaceutical that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Nuclear Radiopharmaceutical total production and demand, 2018-2029, (Units)

Global Nuclear Radiopharmaceutical total production value, 2018-2029, (USD Million)

Global Nuclear Radiopharmaceutical production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (Units)

Global Nuclear Radiopharmaceutical consumption by region & country, CAGR, 2018-2029 & (Units)

U.S. VS China: Nuclear Radiopharmaceutical domestic production, consumption, key domestic manufacturers and share

Global Nuclear Radiopharmaceutical production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (Units)

Global Nuclear Radiopharmaceutical production by Type, production, value, CAGR, 2018-2029, (USD Million) & (Units)

Global Nuclear Radiopharmaceutical production by Application production, value, CAGR, 2018-2029, (USD Million) & (Units)

This reports profiles key players in the global Nuclear Radiopharmaceutical market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Nihon Medi-Physics Co.,Ltd., Curium Pharma, Cardinal Health, Bayer Global, GE Healthcare, Mallinckrodt Pharmaceuticals, Bracco Group, Advanced Molecular-imaging Solution and China Isotope & Radiation, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Nuclear Radiopharmaceutical market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Nuclear Radiopharmaceutical Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Nuclear Radiopharmaceutical Market, Segmentation by Type
Diagnostic
Therapeutic

Global Nuclear Radiopharmaceutical Market, Segmentation by Application
Oncology
Thyroid
Cardiology
Others

Companies Profiled:
Nihon Medi-Physics Co.,Ltd.
Curium Pharma
Cardinal Health
Bayer Global
GE Healthcare
Mallinckrodt Pharmaceuticals
Bracco Group
Advanced Molecular-imaging Solution
China Isotope & Radiation
Ciaeriar
Shanghai Atom Kexing Pharmaceutical Co.,Ltd.

Key Questions Answered

1. How big is the global Nuclear Radiopharmaceutical market?

2. What is the demand of the global Nuclear Radiopharmaceutical market?

3. What is the year over year growth of the global Nuclear Radiopharmaceutical market?

4. What is the production and production value of the global Nuclear Radiopharmaceutical market?

5. Who are the key producers in the global Nuclear Radiopharmaceutical market?

6. What are the growth factors driving the market demand?